SC12267 (4SC-101) in Combination With Methotrexate in Patients With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the efficacy, safety and pharmacokinetics of SC12267
(4SC-101, 35 mg) in combination with methotrexate in comparison to methotrexate alone in the
treatment of patients suffering from Rheumatoid Arthritis.